Literature DB >> 17039515

Hypocholesterolemia in chronic anemias with increased erythropoietic activity.

Hanna Shalev1, Joseph Kapelushnik, Asher Moser, Hilla Knobler, Hannah Tamary.   

Abstract

Hypocholesterolemia of unknown etiology has been previously described in various chronic anemias. Few small studies also suggested that those patients have a lower incidence of atherosclerotic events. The aim of our study was to determine the extent of hypocholesterolemia in various types of anemias. We studied 59 patients with chronic anemias associated with high-erythropoietic activity (thalassemia intermedia, congenital dyserythropoietic anemia type I, congenital spherocytosis), 8 patients with low-erythropoietic activity anemias (acquired aplastic anemia, Fanconi anemia, and Diamond Blackfan anemia), and 20 healthy controls. Mean serum cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triglycerides, hemoglobin, serum ferritin, soluble transferrin receptor (STR), and serum erythropoietin levels were determined in each patient. All patients with chronic anemia and increased erythropoietic activity had hypocholesterolemia, whereas none of those with low erythropoietic activity was hypocholesterolemic. Mean serum cholesterol, HDL cholesterol, and LDL cholesterol levels were found to be significantly lower in the high-erythropoietic activity group (80+/-19 mg/dl; 31+/-10 mg/dl; 35+/-14 mg/dl, respectively) compared with the control group (P<0.001; 0.001; 0.001, respectively) and the low-erythropoietic activity group (P<0.001; 0.001; 0.01, respectively). Significant inverse correlation (R2=0.507) was observed between serum cholesterol and STR levels, which in the absence of iron deficiency reflect bone marrow activity. Taken together, our results imply that hypocholesterolemia accompanies anemias with high-erythropoietic activity. We suggest that the high-erythropoitic activity-associated hypocholesterolemia is due to increased cholesterol requirements by the proliferating erythoid cells. Further studies are needed to elucidate the exact mechanism and the possible clinical consequences of this phenomenon. Copyright (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17039515     DOI: 10.1002/ajh.20804

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  30 in total

1.  Depleted nitric oxide and prostaglandin E2 levels are correlated with endothelial dysfunction in β-thalassemia/HbE patients.

Authors:  Sudarat Satitthummanid; Noppacharn Uaprasert; Smonporn Boonyaratavej Songmuang; Ponlapat Rojnuckarin; Piyaratana Tosukhowong; Pranee Sutcharitchan; Suphot Srimahachota
Journal:  Int J Hematol       Date:  2017-05-04       Impact factor: 2.490

2.  Traditional laboratory measures of cardiovascular risk in hereditary spherocytosis.

Authors:  Shelley E Crary; Sarah Troendle; Naveed Ahmad; George R Buchanan
Journal:  Pediatr Blood Cancer       Date:  2010-10       Impact factor: 3.167

3.  Cardiac iron and cardiac disease in males and females with transfusion-dependent thalassemia major: a T2* magnetic resonance imaging study.

Authors:  Maria Marsella; Caterina Borgna-Pignatti; Antonella Meloni; Valeria Caldarelli; Maria Chiara Dell'Amico; Anna Spasiano; Lorella Pitrolo; Eliana Cracolici; Gianluca Valeri; Vincenzo Positano; Massimo Lombardi; Alessia Pepe
Journal:  Haematologica       Date:  2011-01-12       Impact factor: 9.941

4.  Hypocholesterolemia is associated negatively with hemolysate lipid peroxidation in sickle cell anemia patients.

Authors:  Y E Oztas; Oztas Er Yesim; S Sabuncuoglu; Sabuncuoglu Suna; S Unal; Unal Selma; H Ozgunes; Ozgunes Hilal; N Ozgunes; Ozgunes Nuriman
Journal:  Clin Exp Med       Date:  2010-12-30       Impact factor: 3.984

Review 5.  Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk.

Authors:  Sebastiano Calandra; Patrizia Tarugi; Helen E Speedy; Andrew F Dean; Stefano Bertolini; Carol C Shoulders
Journal:  J Lipid Res       Date:  2011-08-23       Impact factor: 5.922

6.  Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I.

Authors:  Hannah Tamary; Hanna Shalev; Galit Perez-Avraham; Meira Zoldan; Itai Levi; Dorine W Swinkels; Toshihiko Tanno; Jeffery L Miller
Journal:  Blood       Date:  2008-09-29       Impact factor: 22.113

Review 7.  Vascular complications after splenectomy for hematologic disorders.

Authors:  Shelley E Crary; George R Buchanan
Journal:  Blood       Date:  2009-07-27       Impact factor: 22.113

8.  Hypocholesterolemia and nonregenerative, suspected immune-mediated, anemia: Report of 3 canine cases.

Authors:  Rachel Robbins; Katrina R Viviano
Journal:  Can Vet J       Date:  2017-10       Impact factor: 1.008

9.  Translocator protein 2 is involved in cholesterol redistribution during erythropoiesis.

Authors:  Jinjiang Fan; Malena B Rone; Vassilios Papadopoulos
Journal:  J Biol Chem       Date:  2009-09-03       Impact factor: 5.157

10.  Association of pro-inflammatory high-density lipoprotein cholesterol with clinical and laboratory variables in sickle cell disease.

Authors:  Kenneth I Ataga; Alan Hinderliter; Julia E Brittain; Susan Jones; Hao Xu; Jianwen Cai; Soyoung Kim; Kirkwood A Pritchard; Cheryl A Hillery
Journal:  Hematology       Date:  2014-05-06       Impact factor: 2.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.